# Sarcopenia and CRP-TyG Index (CTI) as Predictors of Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer

> **NCT07192926** · — · COMPLETED · sponsor: **Ankara Etlik City Hospital** · enrollment: 131 (actual)

## Conditions studied

- Metastatic Non-small Cell Lung Cancer
- Neoplasm

## Interventions

- **DRUG:** Immune Checkpoint Inhibitors

## Key facts

- **NCT ID:** NCT07192926
- **Lead sponsor:** Ankara Etlik City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-15
- **Primary completion:** 2025-12-15
- **Final completion:** 2026-02-19
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07192926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07192926, "Sarcopenia and CRP-TyG Index (CTI) as Predictors of Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07192926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*